Literature Review: Do Mesenchymal Stem Cells Suppress Systemic Cytokines in Lupus and COPD?
A peer-reviewed review of studies examining mesenchymal stem cells, systemic cytokines, lupus, and COPD.
Transverse Myelitis
Regenerative Medicine for Transverse Myelitis
Regenerative Medicine for Transverse Myelitis is an alternative option to help manage symptoms.
Content Review: Michael Healey, M.Ed., C.A.S. Last Updated: September 2026
What Is Transverse Myelitis?
Transverse myelitis, or TM, is an inflammatory injury to the spinal cord that can disrupt communication between the brain and the rest of the body. It can cause weakness, sensory changes, pain, and bladder or bowel symptoms. Symptoms may develop quickly and require prompt medical assessment. TM can occur after an infection, as part of an autoimmune or demyelinating condition such as multiple sclerosis, neuromyelitis optica spectrum disorder, or myelin oligodendrocyte glycoprotein antibody-associated disease, or without a clearly identified cause. The severity and pace of recovery vary widely. Some people improve with treatment and rehabilitation, while others have lasting neurological symptoms.
Common Symptoms
- Weakness, heaviness, or paralysis in one or both legs and sometimes the arms
- Numbness, tingling, burning pain, or altered sensation below the affected area of the spinal cord
- A tight, band-like sensation around the chest or abdomen
- Balance, walking, or coordination problems
- Bladder, bowel, or sexual-function changes
New weakness, difficulty walking, urinary retention, loss of bowel control, or rapidly worsening symptoms require prompt medical evaluation.
Current Medical Treatments
Treatment depends on the severity of symptoms and the suspected cause of inflammation. Early treatment is intended to reduce inflammation, identify any underlying condition, prevent complications, and support recovery.
Standard Treatment Categories
- Corticosteroids: High-dose corticosteroids are commonly used early to reduce inflammation.
- Plasma exchange: This treatment may be considered when symptoms are severe or do not respond adequately to corticosteroids.
- Treatment of an underlying condition: Infection, autoimmune disease, or another contributing condition may require additional treatment.
- Rehabilitation: Physical, occupational, and other therapies can help support movement, daily function, and independence.
- Ongoing symptom management: Pain, spasticity, bladder and bowel problems, mood changes, and other symptoms may need continuing care.
Stem Cell Therapy and Regenerative Medicine Research for Transverse Myelitis
Stem cell therapy for transverse myelitis is an area of early research. Researchers are studying umbilical-cord-derived mesenchymal stromal cells, or UC-MSCs, because they may influence inflammation and immune signaling around injured nervous tissue.
What Researchers Are Studying
- Influence inflammatory and immune-system signaling
- Affect the environment around injured spinal cord tissue
- Be delivered safely and feasibly in carefully selected patients
- Support further study of motor, sensory, or autonomic changes
UC-MSCs release proteins and other signaling molecules that researchers are studying for their possible effects on inflammation and injured nervous tissue. These biological properties are one reason stem cell therapy for TM continues to be investigated as a potential regenerative approach.
Note: Stem cell therapies for transverse myelitis are not FDA-approved and are investigational. Direct human research is limited to a single case report involving surgery, secretome, UC-MSCs, and rehabilitation. The report provides early clinical information on this multi-component approach but cannot establish its safety or effectiveness.
How Stem Cell Therapy for TM Is Being Studied
Most regenerative medicine research related to TM remains early or indirect. Laboratory and animal studies may help researchers understand possible biological mechanisms, but they do not establish patient benefit. The available human case report involved posterior decompression surgery, mesenchymal stem cell-derived secretome, intrathecal umbilical-cord-derived mesenchymal stromal cells, and rehabilitation. This multi-component approach provides early clinical information for continued research.
Recent Clinical Research on Stem Cell Therapy for TM
2025: UC-MSCs and Secretome Case Report Described Motor and Autonomic Improvements
Transverse Myelitis Successfully Treated with Posterior Decompression Followed by Secretome and Mesenchymal Stem Cell Therapy — Read Study
This case report described one child with longitudinally extensive transverse myelitis. According to the report, symptoms began seven days after pneumococcal conjugate vaccination, although the report does not establish that the vaccination caused TM. The child was diagnosed at age two and a half and received posterior decompression surgery, mesenchymal stem cell-derived secretome, three intrathecal administrations of umbilical-cord-derived mesenchymal stromal cells given four weeks apart, and rehabilitation. The authors reported improvements in motor and autonomic function during treatment. These findings add early clinical information on a multi-component approach involving surgery, secretome, UC-MSCs, and rehabilitation for transverse myelitis.
Could Stem Cell Therapy for Transverse Myelitis Be Right for You?
For people with persistent TM-related symptoms, stem cell therapy for transverse myelitis and other regenerative medicine approaches may be topics to discuss with a healthcare provider. A consultation can help review the diagnosis, current symptoms, imaging, treatment history, rehabilitation progress, and goals. It can also clarify what the available research does and does not show.
At Stemedix, we emphasize education, safety, and scientific transparency. Our team offers personalized consultations to review your medical history, imaging, and goals and discuss whether an investigational regenerative approach may be appropriate to explore with your treating clinician.
Medical Disclaimer
This page is for educational purposes only and does not constitute medical advice.
Regenerative cell therapies for transverse myelitis are investigational and are not FDA-approved for this condition. Research findings do not guarantee individual results.
Always consult a qualified healthcare professional before making treatment decisions.
References
- Faried A. et al. Transverse Myelitis Successfully Treated with Posterior Decompression Followed by Secretome and Mesenchymal Stem Cell Therapy. European Journal of Case Reports in Internal Medicine., 2025. PubMed
U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies. FDA
Speak with a Care Coordinator today for a more accurate assessment of your condition and therapy options.
Patient Testimonials
Please see the comments and personal video testimonies on our website to see our patients’ experience and their personal journey to wellness with Stemedix.
SCHEDULE A CONSULTATION
Discover our wide range of treatments by calling us at (800) 531-0831
How Stemedix Helps You Heal
Our Board-Certified Physicians specialize in regenerative medicine. They stay abreast of the latest developments in stem cell research. Each patient is screened and reviewed before being approved for therapy.
Each patient is thoroughly reviewed to ensure their safety for treatment. The physicians will then determine potential benefit candidacy. If approved, a customized treatment plan is offered for the patient.
Stemedix can help coordinate patients with necessary wheelchair transportation, medical equipment, and Care Giving services as needed during their stay. Your Care Coordinator is available for questions and assistance.
Latest Articles on Stem Cell Therapy & Health Awareness
Can PRP or Regenerative Therapy Help Fibromyalgia Symptoms Long-Term?
Platelet-Rich Plasma (PRP) therapy uses growth factors from a patient's own blood to target inflammation and support tissue repair, which may help with fibromyalgia-related pain and fatigue. Research on long-term outcomes is still developing, and results vary by patient. At Stemedix, we design personalized regenerative medicine plans based on each patient's diagnosis, since fibromyalgia symptoms…
Mesenchymal Stem Cells and Neuroinflammation: Understanding the Role of the Secretome
A peer-reviewed review of research on mesenchymal stem cells, their secretome, and neuroinflammation in neurological disorders.
Forward-Thinking Medicine for Transverse Myelitis
Contact us today and let Stemedix provide a worry-free experience accompanied by one of our Care Coordinators to ensure you have the best experience possible!